Transplant immunosuppressive agents in non‐transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus - Concepedia

Concepedia

Publication | Open Access

Transplant immunosuppressive agents in non‐transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus

DOI Full Paper Access

113

Citations

8

References

2005

Year

Nazira Chatur, Alnoor Ramji, Vincent G. Bain, Paul J. Marotta, Cameron N. Ghent, Leslie Lilly, E. Jenny Heathcote, Marc Deschênes, Samuel S. Lee, Urs P. Steinbrecher,

Liver International

Abstract

MMF is effective and well tolerated by patients with autoimmune hepatitis who do not respond to, or are intolerant of, conventional immunosuppressive agents.

References

	Year	Citations

Page 1